<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">CPR</journal-id>
<journal-id journal-id-type="hwp">spcpr</journal-id>
<journal-title>European Journal of Preventive Cardiology</journal-title>
<issn pub-type="ppub">2047-4873</issn>
<issn pub-type="epub">2047-4881</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1741826711400512</article-id>
<article-id pub-id-type="publisher-id">10.1177_1741826711400512</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cardiac rehabilitation</subject>
<subj-group subj-group-type="heading">
<subject>Original scientific papers</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Aerobic interval training reduces blood pressure and improves myocardial function in hypertensive patients</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Molmen-Hansen</surname><given-names>Harald Edvard</given-names></name>
<xref ref-type="aff" rid="aff1-1741826711400512">1</xref>
<xref ref-type="corresp" rid="corresp1-1741826711400512"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Stolen</surname><given-names>Tomas</given-names></name>
<xref ref-type="aff" rid="aff1-1741826711400512">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Tjonna</surname><given-names>Arnt Erik</given-names></name>
<xref ref-type="aff" rid="aff1-1741826711400512">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Aamot</surname><given-names>Inger Lise</given-names></name>
<xref ref-type="aff" rid="aff2-1741826711400512">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Ekeberg</surname><given-names>Inga Schjerve</given-names></name>
<xref ref-type="aff" rid="aff1-1741826711400512">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Tyldum</surname><given-names>Gjertrud Aunet</given-names></name>
<xref ref-type="aff" rid="aff1-1741826711400512">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Wisloff</surname><given-names>Ulrik</given-names></name>
<xref ref-type="aff" rid="aff1-1741826711400512">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Ingul</surname><given-names>Charlotte Bjork</given-names></name>
<xref ref-type="aff" rid="aff1-1741826711400512">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Stoylen</surname><given-names>Asbjorn</given-names></name>
<xref ref-type="aff" rid="aff1-1741826711400512">1</xref>
<xref ref-type="aff" rid="aff3-1741826711400512">3</xref>
</contrib>
</contrib-group>
<aff id="aff1-1741826711400512"><label>1</label>Department of Circulation and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway.</aff>
<aff id="aff2-1741826711400512"><label>2</label>Department of Clinical Service, St Olavs University Hospital, Trondheim, Norway.</aff>
<aff id="aff3-1741826711400512"><label>3</label>Department of Cardiology, St Olavs University Hospital, Trondheim, Norway.</aff>
<author-notes>
<corresp id="corresp1-1741826711400512">Harald Edvard Molmen-Hansen, Department of Circulation and Medical Imaging, Faculty of Medicine, Norwegian University of Science and Technology, Olav Kyrres veg 3, NO-7489 Trondheim, Norway Email: <email>haralhan@ntnu.no</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>4</month>
<year>2012</year>
</pub-date>
<volume>19</volume>
<issue>2</issue>
<fpage>151</fpage>
<lpage>160</lpage>
<history>
<date date-type="rev-recd"><day>1</day><month>11</month><year>2010</year></date>
<date date-type="accepted"><day>22</day><month>1</month><year>2011</year></date>
</history>
<permissions>
<copyright-statement>© The European Society of Cardiology 2011 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav</copyright-statement>
<copyright-year>2011</copyright-year>
<copyright-holder content-type="society">European Society of Cardiology</copyright-holder>
</permissions>
<abstract>
<p><bold>Aims:</bold> Exercise is recommended as prevention, management, and control of all stages of hypertension. There are still controversies about the optimal training dose, frequency, and intensity. We aimed to study the effect of aerobic interval training on blood pressure and myocardial function in hypertensive patients.</p>
<p><bold>Methods and results:</bold> A total of 88 patients (52.0 ± 7.8 years, 39 women) with essential hypertension were randomized to aerobic interval training (AIT) (&gt;90% of maximal heart rate, correlates to 85–90% of VO<sub>2max</sub>), isocaloric moderate intensity continuous training (MIT) (∼70% of maximal heart rate, 60% of VO<sub>2max</sub>), or a control group. Exercise was performed on a treadmill, three times per week for 12 weeks. Ambulatory 24-hour blood pressure (ABP) was the primary endpoint. Secondary endpoints included maximal oxygen uptake (VO<sub>2max</sub>), mean heart rate/24 hour, flow mediated dilatation (FMD), total peripheral resistance (TPR), and myocardial systolic and diastolic function by echocardiography. Systolic ABP was reduced by 12 mmHg (<italic>p</italic> &lt; 0.001) in AIT and 4.5 mmHg (<italic>p</italic> = 0.05) in MIT. Diastolic ABP was reduced by 8 mmHg (<italic>p</italic> &lt; 0.001) in AIT and 3.5 mmHg (<italic>p</italic> = 0.02) in MIT. VO<sub>2max</sub> improved by 15% (<italic>p</italic> &lt; 0.001) in AIT and 5% (<italic>p</italic> &lt; 0.01) in MIT. Systolic myocardial function improved in both exercise groups, diastolic function in the AIT group only. TPR reduction and increased FMD were only observed in the AIT group.</p>
<p><bold>Conclusions:</bold> This study indicates that the blood pressure reducing effect of exercise in essential hypertension is intensity dependent. Aerobic interval training is an effective method to lower blood pressure and improve other cardiovascular risk factors.</p>
</abstract>
<kwd-group>
<kwd>Endothelial function</kwd>
<kwd>exercise</kwd>
<kwd>hypertension</kwd>
<kwd>tissue Doppler echocardiography</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-1741826711400512" sec-type="intro"><title>Introduction</title>
<p>Hypertension is an important risk factor for cardiovascular diseases (CVD), affecting about 1 billion people worldwide, and is the top global risk factor for mortality.<sup><xref ref-type="bibr" rid="bibr1-1741826711400512">1</xref></sup> Low aerobic fitness is a strong predictor for future CVD and all-cause mortality in both healthy and CVD patients, including those with hypertension.<sup><xref ref-type="bibr" rid="bibr2-1741826711400512">2</xref></sup><sup>–</sup><sup><xref ref-type="bibr" rid="bibr4-1741826711400512">4</xref></sup> A recent observational study showed that this increased risk was substantially reduced by a relatively small increase in exercise capacity, and that the risk declined progressively with increasing aerobic capacity.<sup><xref ref-type="bibr" rid="bibr2-1741826711400512">2</xref></sup> Physical activity is recommended as prevention, treatment, and control of all stages of hypertension.<sup><xref ref-type="bibr" rid="bibr5-1741826711400512">5</xref></sup><sup>–</sup><sup><xref ref-type="bibr" rid="bibr8-1741826711400512">8</xref></sup> Several studies have shown that high-intensity aerobic interval training (AIT) improves aerobic fitness and reduces several CVD risk factors more than moderate intensity continuous training (MIT).<sup><xref ref-type="bibr" rid="bibr9-1741826711400512">9</xref></sup><sup>–</sup><sup><xref ref-type="bibr" rid="bibr13-1741826711400512">13</xref></sup> There is growing evidence that vigorous training compared to moderate- and low-intensity training elicits more CVD benefits, also in hypertensive patients.<sup><xref ref-type="bibr" rid="bibr14-1741826711400512">14</xref>,<xref ref-type="bibr" rid="bibr15-1741826711400512">15</xref></sup> Several meta-analyses indicate little or no intensity-dependent effect of exercise training for the reduction of the blood pressure.<sup><xref ref-type="bibr" rid="bibr5-1741826711400512">5</xref>,<xref ref-type="bibr" rid="bibr6-1741826711400512">6</xref>,<xref ref-type="bibr" rid="bibr16-1741826711400512">16</xref></sup> However, the majority of hypertension studies have examined the effect of exercise intensities below 85% of maximal heart rate (HR<sub>max</sub>), and few studies have compared different intensities directly.<sup><xref ref-type="bibr" rid="bibr5-1741826711400512">5</xref>,<xref ref-type="bibr" rid="bibr16-1741826711400512">16</xref></sup></p>
<p>The aim of this study was to determine the effect of AIT (&gt;90% of HR<sub>max</sub>) to isocaloric MIT (∼70% of HR<sub>max</sub>) on blood pressure reduction and myocardial function in patients with mild to moderate essential hypertension.</p>
</sec>
<sec id="sec2-1741826711400512" sec-type="methods"><title>Methods</title>
<sec id="sec3-1741826711400512" sec-type="subjects"><title>Subjects</title>
<p>Eighty-eight patients (52.0 ± 7.8 years, 39 women) were recruited through an advertisement in a local newspaper. Inclusion criteria were: age &lt;65 years, essential hypertension stage 1–2, defined as systolic blood pressure (SBP) 140–179 mmHg and/or diastolic blood pressure (DBP) 90–109 mmHg.<sup><xref ref-type="bibr" rid="bibr7-1741826711400512">7</xref></sup> Patients with secondary hypertension, indications of end organ affection, left ventricular hypertrophy, retinal changes, microalbuminuria, or three or more risk factors for CVD,<sup><xref ref-type="bibr" rid="bibr7-1741826711400512">7</xref></sup> as well as patients using more than one antihypertensive drug, were excluded. A standard 12-lead electrocardiogram was taken before the start of the study to exclude myocardial hypertrophy.<sup><xref ref-type="bibr" rid="bibr7-1741826711400512">7</xref></sup> Before inclusion, 39 patients used an antihypertensive drug, which was terminated, and the patients observed for a wash-out period of 1 month before inclusion. Measurements done at the end of this period were used as baseline. All measurements used in the analysis were done before and after the training period. The study protocol was approved by the regional committee for medical ethical research, followed the ethical directives according to the Declaration of Helsinki and all subjects gave their written informed consent.</p>
</sec>
<sec id="sec4-1741826711400512"><title>Randomization and interventions</title>
<p>The patients were randomized into three groups:
<list id="list1-1741826711400512" list-type="order">
<list-item><p>AIT, consisting of 10 minutes warm up at ∼60% of HR<sub>max</sub>, 4 × 4 minute intervals at 90–95% of HR<sub>max</sub> (corresponding to 85–90% of VO<sub>2max</sub>) walking/running uphill on a treadmill, with 3 minutes active pause between the exercise bouts at 60–70% HR<sub>max</sub>. The session was terminated with 3 minutes cool down. Total exercise time was 38 minutes.</p></list-item>
<list-item><p>MIT, walking/running on treadmill at 70% of HR<sub>max</sub> (corresponding to 60% of VO<sub>2max</sub>), for 47 minutes to ensure similar isocaloric training sessions to the AIT group.<sup><xref ref-type="bibr" rid="bibr11-1741826711400512">11</xref></sup></p></list-item>
<list-item><p>The control group received standard recommendation for patients with essential hypertension, including regular light-moderate intensity exercise,<sup><xref ref-type="bibr" rid="bibr7-1741826711400512">7</xref></sup> but without supervision.</p></list-item>
</list></p>
<p>Groups 1 and 2 exercised at our laboratory three times per week for 12 weeks, supervised by a sports physiologist. A completion criterion for the study was 90% compliance with the training programme. Training intensity was controlled by heart rate monitors (Polar Electro, Kempele, Finland).</p>
</sec>
<sec id="sec5-1741826711400512"><title>Blood pressure and heart rate</title>
<p>Ambulatory blood pressure monitoring was performed at baseline and followed up with an oscillometric TM-2430 recorder (A&amp;D, Tokyo, Japan).<sup><xref ref-type="bibr" rid="bibr17-1741826711400512">17</xref></sup> The device measured blood pressure and heart rate (HR) at 15-minute intervals during daytime (6 a.m.–10 p.m.), and at 30-minute intervals during night-time (10 p.m.–6 a.m., which defined night-time in this study). The procedure and analytic methods are thoroughly described.<sup><xref ref-type="bibr" rid="bibr7-1741826711400512">7</xref></sup> Measurements were done after at least 1 day after an exercise session. The recordings were accepted if at least 75% of the recordings were obtained. Values were deleted if SBP &gt;250 mmHg and &lt;80 mmHg, and/or DBP &gt;140 and &lt;40 mmHg, and/or if pulse pressure &gt;110 mmHg or &lt;20 mmHg. The devices were programmed to do another measurement if there was a change between consecutive readings of SBP &gt;50 mmHg, DBP &gt;40 mmHg, and pulse pressure&gt;50 mmHg. If the ABP failed to measure the blood pressure, another ABP was performed. The values used for statistical analyses are average systolic and diastolic pressures and HR.</p>
</sec>
<sec id="sec6-1741826711400512"><title>Exercise testing and endothelial function</title>
<p>VO<sub>2max</sub> and HR<sub>max</sub> were tested using an individualized graded ramp protocol on a treadmill with MetaMax II (Cortex, Leipzig, Germany) as previously described.<sup><xref ref-type="bibr" rid="bibr18-1741826711400512">18</xref></sup> After a 10-minute warm-up, a facemask was placed on the subject’s face for metabolic measurements using a Metamax 2 (Cortex, Leipzig, Germany). Incline was constant at 10% and band speed increased every minute until VO<sub>2</sub> levelled off (&lt;2 ml/kg/min increase) despite increased work load was reached, and a respiratory exchange ratio &gt;1.10. HR was measured subsequently 1 and 2 minutes after terminating the test for assessment of HR recovery.</p>
<p>Endothelial function was measured by ultrasound (14 MHz linear vascular probe) as flow-mediated dilatation (FMD) due to reactive hyperaemia after occlusion of the brachial artery according to a standardized method.<sup><xref ref-type="bibr" rid="bibr19-1741826711400512">19</xref></sup> Endothelium-independent dilation was measured after administering 0.5 mg nitroglycerin sublingually.</p>
</sec>
<sec id="sec7-1741826711400512"><title>Echocardiography and total peripheral resistance</title>
<p>Fifty-one subjects had an echocardiogram and were examined at rest by an experienced cardiologist using a Vivid 7 scanner (GE Vingmed Ultrasound, Horten, Norway) with a M3S probe.<sup><xref ref-type="bibr" rid="bibr10-1741826711400512">10</xref></sup> B-mode images were recorded with a frame rate of 54 frames/second. Left ventricular volume (LV)and ejection fraction (EF) were calculated from apical four and two chamber recordings by modified biplane Simpson’s method. Left ventricular inflow velocity was measured by pulsed Doppler with the sample volume at the tip level of mitral valves. Measurements included early diastolic filling (E), late diastolic filling (A), and isovolumic relaxation time (IVRT). The stroke volume was measured by Doppler flow measurement in the left ventricular outflow tract (LVOT) and LVOT diameter. Cardiac output (CO) was calculated automatically by the echocardiographic scanner and multiplies stroke volume and HR during the echocardiographic examination. Pulsed tissue Doppler recordings from the mitral annulus were obtained from the septal and lateral points in four-chamber and in the anterior and inferior points in two-chamber views, as well as from the lateral corner of the tricuspid annulus. Peak annulus velocity in systole (S′) early diastole (E′), and late diastole (A′) were measured as an average of the four points for the LV.</p>
<p>Total periperal resistance (TPR) was calculated by mean arterial pressure (mean values from ambulatory 24 hour measurements) divided by cardiac output and multiplied by 80. All echo-data were recorded and analysed by experienced personnel blinded to the patients’ group assignment.</p>
</sec>
<sec id="sec8-1741826711400512"><title>Quality of life</title>
<p>Quality of life (QoL) was measured at baseline and at follow up, using the Short-Form 36-item Health Survey (QualityMetric, Lincoln, RI, USA).</p>
</sec>
<sec id="sec9-1741826711400512"><title>Statistical analyses</title>
<p>The principal outcome variable was ABP and this variable was analysed using a linear model for correction for baseline value (ANCOVA) which is the preferred approach for analysing randomized trials with baseline and follow-up measurements.<sup><xref ref-type="bibr" rid="bibr20-1741826711400512">20</xref></sup> 24-hour ambulatory blood pressure measurements display small variability because of a high number of measurements. Standard deviation is about 5 mmHg. The hypothesis claims that moderate intensity training will reduce systolic blood pressure by 5 mmHg and that high-intensity aerobic interval training will have an additional effect of 5 mmHg reduction. To detect a difference of 5 mmHg with a level of significance of 5% and a statistical power of 80% we estimated that we needed 29 patients in each group.</p>
<p>The between-group comparison was done with post hoc Bonferroni correction for multiple comparisons. Within-group differences were analysed with students paired T-test. Data are presented as mean (SD). All statistical analyses were done with SPSS 15 (SPSS, Inc, Chicago).</p>
<p>The randomization code was developed using a computer random number generator.</p>
</sec>
</sec>
<sec id="sec10-1741826711400512" sec-type="results"><title>Results</title>
<sec id="sec11-1741826711400512"><title>Patients and exercise training</title>
<p>No differences were found between-groups at baseline regarding anthropometric or physiological measurements (<xref ref-type="table" rid="table1-1741826711400512">Table 1</xref>). In total 17% of the patients did not complete the study (<xref ref-type="fig" rid="fig1-1741826711400512">Figure 1</xref>). There was no difference in the rate of drop outs between the two training groups (<xref ref-type="fig" rid="fig1-1741826711400512">Figure 1</xref>). Thus, the total patient population for analysis was done with 25 patients in AIT, 23 in MIT and 25 in the control group (<xref ref-type="fig" rid="fig1-1741826711400512">Figure 1</xref>).
<fig id="fig1-1741826711400512" position="float"><label>Figure 1.</label><caption><p>Randomization profile showing flow of patients in the three training groups; aerobic interval group (AIT), moderate intensity group (MIT) and control group (C).</p></caption><graphic xlink:href="10.1177_1741826711400512-fig1.tif"/></fig>
<table-wrap id="table1-1741826711400512" position="float"><label>Table 1.</label><caption><p>Baseline characteristics</p></caption>
<graphic alternate-form-of="table1-1741826711400512" xlink:href="10.1177_1741826711400512-table1.tif"/>
<table frame="hsides"><thead align="left">
<tr><th>Characteristic</th>
<th>AIT</th>
<th>MIT</th>
<th>Control</th></tr></thead>
<tbody align="left">
<tr>
<td>Male/female</td>
<td>16/15</td>
<td>16/12</td>
<td>17/12</td></tr>
<tr>
<td>Age (years)</td>
<td>52.5 ± 7.4</td>
<td>53.6 ± 6.5</td>
<td>51.3 ± 9.2</td></tr>
<tr>
<td>BMI (kg/m<sup>2</sup>)</td>
<td>26.8 ± 4.1</td>
<td>27.9 ± 3.2</td>
<td>28.8 ± 3.7</td></tr>
<tr>
<td>ABP systolic (mmHg)</td>
<td>153.0 ± 12.3</td>
<td>151.0 ± 12.1</td>
<td>153.5 ± 11.3</td></tr>
<tr>
<td>ABP diastolic (mmHg)</td>
<td>93.0 ± 8.2</td>
<td>92.0 ± 5.9</td>
<td>92.5 ± 8.5</td></tr>
<tr>
<td>HR (beats/min/24 hour)</td>
<td>73.0 ± 7.5</td>
<td>72.2 ± 7.4</td>
<td>73.4 ± 7.4</td></tr>
<tr>
<td>VO<sub>2max</sub> (ml/kg/min)</td>
<td>36.3 ± 8.8</td>
<td>34.0 ± 7.0</td>
<td>34.7 ± 7.8</td></tr>
<tr>
<td>Total chol (mmol/l)</td>
<td>5.56 ± 0.83</td>
<td>5.75 ± 1.04</td>
<td>6.08 ± 0.99</td></tr>
<tr>
<td>Triglycerids (mmol/l)</td>
<td>1.25 ± 0.49</td>
<td>1.28 ± 0.44</td>
<td>1.19 ± 0.52</td></tr>
<tr>
<td>Glucose (mmol/l)</td>
<td>4.98 ± 0.57</td>
<td>5.08 ± 0.79</td>
<td>5.20 ± 0.89</td></tr>
<tr>
<td>Creatinin (µmol/l)</td>
<td>76.0 ± 12.7</td>
<td>77.5 ± 11.3</td>
<td>74.6 ± 13.8</td></tr>
<tr>
<td>Haemoglobin (g/dl)</td>
<td>14.5 ± 0.8</td>
<td>14.6 ± 1.0</td>
<td>14.8 ± 1.2</td></tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-1741826711400512"><p>Values are mean ± SD.</p></fn>
<fn id="table-fn2-1741826711400512"><p>No differences were found between-groups at baseline regarding anthropometric and physiological measurements.</p></fn>
<fn id="table-fn3-1741826711400512"><p>ABP, ambulatory 24-hour blood pressure; AIT, aerobic interval training; BMI, body mass index; HR, heart rate; MIT, moderate intensity training; VO<sub>2max</sub>, maximal oxygen uptake.</p></fn></table-wrap-foot>
</table-wrap></p>
<p>BMI decreased by 0.45 kg/m<sup>2</sup> (<italic>p</italic> = 0.04<italic>)</italic> and 0.46 kg/m<sup>2</sup> (NS) in MIT and AIT, respectively, whereas no changes were seen in the control group (28.8 ± 3.7 to 28.7 ± 3.8, NS).</p>
</sec>
<sec id="sec12-1741826711400512"><title>Ambulatory blood pressure and heart rate</title>
<p>The results for 24-hour blood pressures and HR are illustrated in <xref ref-type="fig" rid="fig2-1741826711400512">Figure 2</xref> and numbered in <xref ref-type="table" rid="table2-1741826711400512">Table 2</xref>. The AIT and MIT groups reduced systolic ABP by 12.0 mmHg (<italic>p</italic> &lt; 0.001) and 4.5 mmHg (<italic>p</italic> = 0.05), respectively (between-group comparison of blood pressure reducing effect, <italic>p</italic> = 0.02). Systolic ABP at daytime was reduced in both training groups, with 13.0 mmHg in the AIT group (<italic>p</italic> &lt; 0.001) and 5.0 mmHg in the MIT group (<italic>p</italic> = 0.04; between-group differences, NS), whereas systolic ABP at night in the AIT group was significant lowered by 10.5 mmHg (<italic>p</italic> &lt; 0.001) and was different from the MIT group (<italic>p</italic> = 0.05), but not compared with the reduction of 5.5 mmHg observed in the control group (NS). In the AIT group 28% of the subjects obtained a reduction of systolic ABP more than 15 mmHg, and 36% reduced systolic ABP between 5–15 mmHg and the 36% last subjects achieved less than 5 mmHg reduction of systolic ABP. About 24% of the subjects in the AIT group became normotone (&lt;130 mmHg systolic ABP). On the other hand, only one person in the MIT group and one person in the control group obtained normotensive values after the study period.
<fig id="fig2-1741826711400512" position="float"><label>Figure 2.</label><caption><p>Ambulatory blood pressure (ABP) during 24 hours displayed as mean value at baseline and follow up in the three training groups; aerobic interval group (AIT), moderate intensity group (MIT) and control group (C). Variation is displayed as standard error of the mean. Only comparisons between AIT and MIT are shown. *<italic>p</italic> &lt; 0.05 between AIT and MIT in blood pressure reduction.</p></caption><graphic xlink:href="10.1177_1741826711400512-fig2.tif"/></fig>
<table-wrap id="table2-1741826711400512" position="float"><label>Table 2.</label><caption><p>Ambulatory blood pressure, day and night-time</p></caption>
<graphic alternate-form-of="table2-1741826711400512" xlink:href="10.1177_1741826711400512-table2.tif"/>
<table frame="hsides"><thead align="left">
<tr><th/>
<th colspan="3">AIT (<italic>n</italic> = 25)<hr/></th>
<th colspan="3">MIT (<italic>n</italic> = 23)<hr/></th>
<th colspan="3">Control (<italic>n</italic> = 25)<hr/></th></tr>
<tr><th>Measurement</th>
<th>Baseline</th>
<th>Follow-up</th>
<th><italic>p</italic>-values (within group/ between AIT-MIT)</th>
<th>Baseline</th>
<th>Follow-up</th>
<th><italic>p</italic>-value within group</th>
<th>Baseline</th>
<th>Follow-up</th>
<th><italic>p</italic>-value within group</th></tr></thead>
<tbody align="left">
<tr>
<td>ABP Sys (mmHg)</td>
<td>153.0 ± 12.3</td>
<td>141.0 ± 12.5</td>
<td>&lt;0.001/0.02</td>
<td>151.0 ± 12.1</td>
<td>146.5 ± 13.1</td>
<td>0.05</td>
<td>153.5 ± 11.3</td>
<td>151.5 ± 16.0</td>
<td>0.32</td></tr>
<tr>
<td>ABP Dia (mmHg)</td>
<td>93.0 ± 8.2</td>
<td>85.0 ± 8.1</td>
<td>&lt;0.001/0.06</td>
<td>92.0 ± 5.9</td>
<td>88.5 ± 8.4</td>
<td>0.02</td>
<td>92.5 ± 8.5</td>
<td>90.5 ± 11.5</td>
<td>0.20</td></tr>
<tr>
<td>HR (beats/min/24 hour)</td>
<td>73.0 ± 7.5</td>
<td>69.3 ± 8.1</td>
<td>&lt;0.01 /0.09</td>
<td>72.2 ± 7.4</td>
<td>72.0 ± 7.4</td>
<td>0.89</td>
<td>73.4 ± 7.4</td>
<td>73.7 ± 7.8</td>
<td>0.82</td></tr>
<tr>
<td>ABP Sys D (mmHg)</td>
<td>159.0 ± 12.8</td>
<td>146.0 ± 11.0</td>
<td>&lt;0.001/0.09</td>
<td>155.5 ± 12.5</td>
<td>150.5 ± 12.0</td>
<td>0.04</td>
<td>156.5 ± 12.4</td>
<td>155.5 ± 16.5</td>
<td>0.70</td></tr>
<tr>
<td>ABP Sys N (mmHg)</td>
<td>139.5 ± 14.4</td>
<td>129.0 ± 16.2</td>
<td>&lt;0.001/0.05</td>
<td>132.0 ± 14.5</td>
<td>131.5 ± 12.8</td>
<td>0.85</td>
<td>140.5 ± 14.0</td>
<td>135.0 ± 16.2</td>
<td>0.04</td></tr>
<tr>
<td>ABP Dia D (mmHg)</td>
<td>97.5 ± 8.7</td>
<td>89.0 ± 7.5</td>
<td>&lt;0.001/0.48</td>
<td>94.0 ± 5.3</td>
<td>90.0 ± 6.6</td>
<td>0.03</td>
<td>95.5 ± 9.6</td>
<td>94.0 ± 10.0</td>
<td>0.29</td></tr>
<tr>
<td>ABP Dia N (mmHg)</td>
<td>84.5 ± 9.8</td>
<td>79.3 ± 10.0</td>
<td>&lt;0.01/0.78</td>
<td>81.0 ± 6.0</td>
<td>79.5 ± 5.9</td>
<td>0.38</td>
<td>85.0 ± 10.0</td>
<td>82.5 ± 11.8</td>
<td>0.17</td></tr>
<tr>
<td>HR D (beats/min/24 hour)</td>
<td>76.2 ± 8.6</td>
<td>73.2 ± 9.0</td>
<td>0.04/0.30</td>
<td>74.7 ± 8.1</td>
<td>74.9 ± 8.7</td>
<td>0.83</td>
<td>76.5 ± 8.2</td>
<td>75.2 ± 7.4</td>
<td>0.39</td></tr>
<tr>
<td>HR N (beats/min/24 hour)</td>
<td>66.0 ± 9.6</td>
<td>61.2 ± 7.1</td>
<td>0.01/0.26</td>
<td>65.3 ± 8.6</td>
<td>64.4 ± 7.1</td>
<td>0.49</td>
<td>66.1 ± 7.6</td>
<td>64.9 ± 7.6</td>
<td>0.38</td></tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn4-1741826711400512"><p>Values are mean ± SD. Only comparisons between AIT and MIT are shown.</p></fn>
<fn id="table-fn5-1741826711400512"><p>ABP, mean ambulatory 24-hour blood pressure; AIT, aerobic interval training; D, daytime; Dia, diastolic; HR, 24-hour mean heart rate; MIT, moderate intensity training; N, night-time; Sys; systolic.</p></fn></table-wrap-foot>
</table-wrap></p>
<p>Diastolic ABP was reduced by 8.0 mmHg in the AIT group (<italic>p</italic> &lt; 0.001) and 3.5 mmHg in the MIT group (<italic>p</italic> = 0.02; between-group differences, NS). Diastolic ABP at daytime was reduced by 8.5 mmHg in the AIT group (<italic>p</italic> &lt; 0.001) and 4.0 mmHg in the MIT group (<italic>p</italic> = 0.03; between-group differences, NS). The reduction in diastolic ABP at night was only reduced in the AIT group (5.0 mmHg, <italic>p</italic> &lt; 0.01; group differences, NS).</p>
<p>Only the AIT group achieved a reduction in HR<sub>mean</sub>, with 3.8 beats/min/24 hour (<italic>p</italic> &lt; 0.01) HR<sub>mean</sub> at day- and night-time were significant reduced only in AIT by 3 beats/min/15 hours (<italic>p</italic> &lt; 0.01) and 4.8 beats/min/9 hours (<italic>p</italic> = 0.01), respectively.</p>
</sec>
<sec id="sec13-1741826711400512"><title>Exercise testing and endothelial function</title>
<p>VO<sub>2max</sub> increased by 15% after AIT (<italic>p</italic> &lt; 0.001) and 5% after MIT (<italic>p</italic> &lt; 0.01; group differences, <italic>p</italic> = 0.001; <xref ref-type="table" rid="table3-1741826711400512">Table 3</xref>). Only the AIT group achieved a significant improvement in heart rate recovery with 7 beats/min (<italic>p</italic> = 0.01) and 8 beats/min (<italic>p</italic> = 0.04) recorded 1 and 2 minute post-exercise, respectively (<xref ref-type="table" rid="table3-1741826711400512">Table 3</xref>).
<table-wrap id="table3-1741826711400512" position="float"><label>Table 3.</label><caption><p>Physiological measurements</p></caption>
<graphic alternate-form-of="table3-1741826711400512" xlink:href="10.1177_1741826711400512-table3.tif"/>
<table frame="hsides"><thead align="left">
<tr><th/>
<th colspan="3">AIT (<italic>n</italic> = 25)<hr/></th>
<th colspan="3">MIT (<italic>n</italic> = 23)<hr/></th>
<th colspan="3">Control (<italic>n</italic> = 25)<hr/></th></tr>
<tr><th>Measurement</th>
<th>Baseline</th>
<th>Follow up</th>
<th><italic>p</italic>-value</th>
<th>Baseline</th>
<th>Follow up</th>
<th><italic>p</italic>-value</th>
<th>Baseline</th>
<th>Follow up</th>
<th><italic>p</italic>-value</th></tr></thead>
<tbody align="left">
<tr>
<td>VO<sub>2max</sub> (ml/kg/min)</td>
<td>36.3 ± 8.8</td>
<td>41.5 ± 10.6</td>
<td>&lt;0.001<sup><xref ref-type="table-fn" rid="table-fn8-1741826711400512">a</xref></sup></td>
<td>34.0 ± 7.0</td>
<td>35.8 ± 6.9</td>
<td>&lt;0.01</td>
<td>34.7 ± 7.8</td>
<td>35.7 ± 7.6</td>
<td>0.06</td></tr>
<tr>
<td>FMD (% dilatation)</td>
<td>6.49 ± 3.71</td>
<td>10.66 ± 5.00</td>
<td>&lt;0.01<sup><xref ref-type="table-fn" rid="table-fn8-1741826711400512">a</xref></sup></td>
<td>6.50 ± 5.01</td>
<td>7.11 ± 5.10</td>
<td>0.70</td>
<td>8.01 ± 4.62</td>
<td>8.91 ± 5.20</td>
<td>0.39</td></tr>
<tr>
<td>HR red 1 min (beats/min)</td>
<td>149.7 ± 13.9</td>
<td>143.1 ± 14.9</td>
<td>0.01<sup><xref ref-type="table-fn" rid="table-fn8-1741826711400512">a</xref></sup></td>
<td>149.4 ± 11.0</td>
<td>151.4 ± 9.8</td>
<td>0.35</td>
<td>149.5 ± 16.0</td>
<td>149.3 ± 14.5</td>
<td>0.90</td></tr>
<tr>
<td>HR red 2 min (beats/min)</td>
<td>128.9 ± 16.2</td>
<td>120.9 ± 14.9</td>
<td>0.04</td>
<td>129.0 ± 10.5</td>
<td>126.6 ± 12.1</td>
<td>0.86</td>
<td>123.6 ± 16.7</td>
<td>127.5 ± 12.9</td>
<td>0.24</td></tr>
<tr>
<td>Peak HR (beats/min)</td>
<td>184.0 ± 9.7</td>
<td>180.0 ± 9.9</td>
<td>0.02</td>
<td>181.5 ± 7.8</td>
<td>182.5 ± 9.2</td>
<td>0.65</td>
<td>180.0 ± 12.1</td>
<td>182.5 ± 11.9</td>
<td>0.06</td></tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn6-1741826711400512"><p>Values are mean ± SD. Only comparisons between AIT and MIT are shown.</p></fn>
<fn id="table-fn7-1741826711400512"><p>AIT, aerobic interval training; FMD, flow-mediated dilatation; HR red 1 min and HR red 2 min, heart rate recovery/reduction after 1 and 2 minutes after test, respectively; MIT, moderate intensity training; Peak HR, peak heart rate; VO<sub>2max</sub>, maximal oxygen uptake.</p></fn>
<fn id="table-fn8-1741826711400512"><label>a</label><p><italic>p</italic>-value≤0.05 between AIT and MIT.</p></fn></table-wrap-foot>
</table-wrap></p>
<p>Endothelial function improved only after AIT (<italic>p</italic> &lt; 0.01 within-group, between-group differences, <italic>p</italic> = 0.02). Endothelial-independent dilatation did not change.</p>
</sec>
<sec id="sec14-1741826711400512"><title>Echocardiography and total peripheral resistance</title>
<p>Only the AIT group improved the ejection fraction, stroke volume, systolic flow velocity, end-diastolic volume (11%, <italic>p</italic> = 0.01), and early diastolic mitral annulus tissue velocity, E′ (14%, <italic>p</italic> &lt; 0.001) (<xref ref-type="table" rid="table4-1741826711400512">Table 4</xref>). Systolic mitral annulus tissue velocity, S′ increased by 15% (<italic>p</italic> &lt; 0.001) after AIT and 8% (<italic>p</italic> = 0.04) after MIT. Interventricular septum thickness was within the normal range before and after the training period in all groups. No significant changes were seen on conventional diastolic markers (E, A, deceleration time (DT)). The isovolumic relaxation rate decreased significantly in the AIT group only, with 16% (<italic>p</italic> &lt; 0.01). No changes were seen in either group regarding neither posterior wall thickness nor left ventricular mass. TPR, decreased by 18.4% (<italic>p</italic> = 0.03) in AIT and 12.8% (NS) in MIT (<xref ref-type="table" rid="table4-1741826711400512">Table 4</xref>).
<table-wrap id="table4-1741826711400512" position="float"><label>Table 4.</label><caption><p>Results from echocardiographic measurements</p></caption>
<graphic alternate-form-of="table4-1741826711400512" xlink:href="10.1177_1741826711400512-table4.tif"/>
<table frame="hsides"><thead align="left">
<tr><th/>
<th colspan="3">AIT (<italic>n</italic> = 17)<hr/></th>
<th colspan="3">MIT (<italic>n</italic> = 16)<hr/></th>
<th colspan="3">Control (<italic>n</italic> = 18)<hr/></th></tr>
<tr><th>Measurement</th>
<th>Baseline</th>
<th>Follow up</th>
<th><italic>p</italic>-within group</th>
<th>Baseline</th>
<th>Follow up</th>
<th><italic>p</italic>-within group</th>
<th>Baseline</th>
<th>Follow up</th>
<th><italic>p</italic>-within group</th></tr></thead>
<tbody align="left">
<tr>
<td>EF (%)</td>
<td>58.0 ± 4.5</td>
<td>64.5 ± 6.7</td>
<td>&lt;0.001<sup><xref ref-type="table-fn" rid="table-fn11-1741826711400512">a</xref></sup></td>
<td>59.5 ± 7.6</td>
<td>61.0 ± 8.7</td>
<td>0.25</td>
<td>59.0 ± 9.3</td>
<td>58.0 ± 7.8</td>
<td>0.50</td></tr>
<tr>
<td>EDV (ml)</td>
<td>110 ± 31</td>
<td>122 ± 31</td>
<td>0.01</td>
<td>116 ± 22</td>
<td>117 ± 24</td>
<td>0.79</td>
<td>120 ± 21</td>
<td>123 ± 25</td>
<td>0.55</td></tr>
<tr>
<td>SV (ml)</td>
<td>72.1 ± 11.7</td>
<td>80.1 ± 14.8</td>
<td>0.02</td>
<td>68.3 ± 15.4</td>
<td>71.1 ± 18.2</td>
<td>0.48</td>
<td>75.3 ± 16.7</td>
<td>72.2 ± 13.1</td>
<td>0.29</td></tr>
<tr>
<td>CO (l/min)</td>
<td>4.6 ± 0.7</td>
<td>5.2 ± 0.9</td>
<td>0.05</td>
<td>4.5 ± 1.1</td>
<td>5.0 ± 1.3</td>
<td>0.09</td>
<td>5.3 ± 1.27</td>
<td>5.0 ± 1.04</td>
<td>0.25</td></tr>
<tr>
<td>HR at rest (b/min)</td>
<td>65.0 ± 6.0</td>
<td>66.5 ± 9.0</td>
<td>0.50</td>
<td>65.5 ± 11.0</td>
<td>72.0 ± 12.0</td>
<td>0.11</td>
<td>71.0 ± 10.0</td>
<td>69 ± 8.0</td>
<td>0.45</td></tr>
<tr>
<td>IVRT (m/s)</td>
<td>96.5 ± 11.5</td>
<td>81.0 ± 13.6</td>
<td>0.02</td>
<td>91.0 ± 29.9</td>
<td>89.0 ± 23.3</td>
<td>0.59</td>
<td>102 ± 13.7</td>
<td>97.0 ± 10.1</td>
<td>0.12</td></tr>
<tr>
<td>S (m/s)</td>
<td>0.96 ± 0.14</td>
<td>1.05 ± 0.14</td>
<td>0.03</td>
<td>0.94 ± 0.13</td>
<td>0.94 ± 0.15</td>
<td>0.95</td>
<td>1.09 ± 0.17</td>
<td>0.97 ± 0.97</td>
<td>0.07</td></tr>
<tr>
<td>E (m/s)</td>
<td>0.74 ± 0.15</td>
<td>0.77 ± 0.16</td>
<td>0.40</td>
<td>0.67 ± 0.14</td>
<td>0.66 ± 0.15</td>
<td>0.74</td>
<td>0.70 ± 0.21</td>
<td>0.69 ± 0.18</td>
<td>0.69</td></tr>
<tr>
<td>A (m/s)</td>
<td>0.62 ± 0.09</td>
<td>0.62 ± 0.09</td>
<td>0.91</td>
<td>0.65 ± 0.11</td>
<td>0.68 ± 0.17</td>
<td>0.49</td>
<td>0.68 ± 0.22</td>
<td>0.64 ± 0.21</td>
<td>0.22</td></tr>
<tr>
<td>S′ cm/s)</td>
<td>6.89 ± 0.90</td>
<td>7.90 ± 1.30</td>
<td>&lt;0.001</td>
<td>7.40 ± 1.20</td>
<td>7.99 ± 1.36</td>
<td>0.03</td>
<td>7.52 ± 1.50</td>
<td>7.07 ± 2.13</td>
<td>0.53</td></tr>
<tr>
<td>E′ (cm/s)</td>
<td>8.06 ± 1.60</td>
<td>9.26 ± 1.80</td>
<td>&lt;0.001<sup><xref ref-type="table-fn" rid="table-fn11-1741826711400512">a</xref></sup></td>
<td>8.93 ± 2.11</td>
<td>8.62 ± 2.27</td>
<td>0.42</td>
<td>8.70 ± 1.81</td>
<td>8.27 ± 1.90</td>
<td>0.24</td></tr>
<tr>
<td>A′ (cm/s)</td>
<td>9.03 ± 1.27</td>
<td>9.52 ± 1.45</td>
<td>0.06</td>
<td>10.16 ± 0.85</td>
<td>10.82 ± 1.76</td>
<td>0.10</td>
<td>9.95 ± 2.00</td>
<td>9.48 ± 2.03</td>
<td>0.39</td></tr>
<tr>
<td>TPR (dynes*sek*cm<sup>-1</sup>)</td>
<td>2050 ± 295</td>
<td>1669 ± 361</td>
<td>0.03</td>
<td>2120 ± 541</td>
<td>1846 ± 599</td>
<td>0.06</td>
<td>1863 ± 580</td>
<td>1891 ± 416</td>
<td>0.80</td></tr>
<tr>
<td>IVS (cm)</td>
<td>0.81 ± 0.15</td>
<td>0.91 ± 0.16</td>
<td>0.08</td>
<td>0.87 ± 0.14</td>
<td>1.05 ± 0.15</td>
<td>0.26</td>
<td>0.96 ± 0.14</td>
<td>0.99 ± 0.15</td>
<td>0.39</td></tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn9-1741826711400512"><p>Values are mean ± SD. Only comparisons between AIT and MIT are shown.</p></fn>
<fn id="table-fn10-1741826711400512"><p>A′, peak annulus tissue velocity during atrial systole; A, peak mitral inflow during atrial systole; AIT, aerobic interval training; CO, cardiac output; E′, peak annulus tissue velocity during early filling; E, peak mitral inflow velocity during early filling; EDV, end diastolic volume; EF, ejection fraction; HR, heart rate (differs from <xref ref-type="table" rid="table1-1741826711400512">Tables 1</xref> and <xref ref-type="table" rid="table2-1741826711400512">2</xref> as this is measured during the echocardiographic examination mainly in order to evaluate other echo measurements); IVRT, isovolumic relaxation time; IVS, interventricular septum thickness; MIT, moderate intensity training; S, systolic peak flow velocity in left ventricular outlet tract; SV, stroke volume; TPR, total peripheral resistance.</p></fn>
<fn id="table-fn11-1741826711400512"><label>a</label><p><italic>p</italic>-value &lt;0.05 between AIT and MIT.</p></fn></table-wrap-foot>
</table-wrap></p>
</sec>
<sec id="sec15-1741826711400512"><title>Quality of life</title>
<p>AIT improved QoL in three sub domains: general health (72 ± 17 – 90 ± 13, <italic>p</italic> = 0.02), social function (93 ± 10 − 99 ± 5, <italic>p</italic> = 0.04) and physical function (91 ± 9 − 97 ± 6, <italic>p</italic> = 0.02). MIT showed improvement in general health (71 ± 22 − 85 ± 16, <italic>p</italic> = 0.03). No significant changes were found in the control group.</p>
</sec>
</sec>
<sec id="sec16-1741826711400512" sec-type="discussion"><title>Discussion</title>
<p>This study indicates that the exercise-induced lowering effect of blood pressure is intensity dependent. In addition, AIT was superior to MIT in terms of improved cardiac function, aerobic capacity, and reduced mean HR.</p>
<sec id="sec17-1741826711400512"><title>Blood pressure, heart rate, and exercise-intensity</title>
<p>Several studies have found the anti-hypertensive effect of endurance training to be in the region of 3–10.5 for systolic and 2–7.6 mmHg for diastolic blood pressure, respectively.<sup><xref ref-type="bibr" rid="bibr5-1741826711400512">5</xref>,<xref ref-type="bibr" rid="bibr6-1741826711400512">6</xref>,<xref ref-type="bibr" rid="bibr8-1741826711400512">8</xref>,<xref ref-type="bibr" rid="bibr16-1741826711400512">16</xref>,<xref ref-type="bibr" rid="bibr21-1741826711400512">21</xref></sup> The effect on 24-hour ABP has been less, with approximately 3.0/3.2 mmHg for systolic and diastolic blood pressure respectively.<sup><xref ref-type="bibr" rid="bibr6-1741826711400512">6</xref></sup> Most reviews have concluded that low-intensity training is more than, or as effective to lower blood pressure as training at higher intensities.<sup><xref ref-type="bibr" rid="bibr6-1741826711400512">6</xref>,<xref ref-type="bibr" rid="bibr8-1741826711400512">8</xref></sup> Even though there has been observed a dose–response relation between exercise intensity and the blood pressure reduction, a statistical significance has not always been demonstrated between different training groups.<sup><xref ref-type="bibr" rid="bibr14-1741826711400512">14</xref>,<xref ref-type="bibr" rid="bibr22-1741826711400512">22</xref></sup> However, the intensity of exercise in most studies has been in the range of low-to-moderate corresponding to 45–85% of HR<sub>max</sub>.<sup><xref ref-type="bibr" rid="bibr5-1741826711400512">5</xref>,<xref ref-type="bibr" rid="bibr8-1741826711400512">8</xref>,<xref ref-type="bibr" rid="bibr21-1741826711400512">21</xref>,<xref ref-type="bibr" rid="bibr23-1741826711400512">23</xref></sup> To our knowledge, this is the first randomized, interventional training study applying exercise intensity above 90% of HR<sub>max</sub>.</p>
<p>The role of intensity is debated, but some studies suggest that some, if not the magnitude of the sustained blood pressure reduction seen after exercise training are due to the reductions that occur immediately after an exercise bout.<sup><xref ref-type="bibr" rid="bibr14-1741826711400512">14</xref>,<xref ref-type="bibr" rid="bibr24-1741826711400512">24</xref></sup> In a recent study by Eicher et al.,<sup><xref ref-type="bibr" rid="bibr25-1741826711400512">25</xref></sup> it was clearly demonstrated that exercising at intensity near 100% of VO<sub>2max</sub> elicited the largest blood pressure reduction after a single bout of exercise. This is in line with our results, but our measurement of ABP was done 1 day after a training session, and probably reflects the chronic adaptations to exercise. Further, they suggest that the American College of Sports Medicine should change their exercise guidelines prescription to hypertensive patients and include more rigorous exercise. In our study AIT reduced the systolic and diastolic blood pressure in a similar way to a single antihypertensive drug.<sup><xref ref-type="bibr" rid="bibr26-1741826711400512">26</xref></sup> About two-thirds of the patients in the AIT group had either a very good or a good effect of AIT, but the last one-third had a low effect. Further and larger studies are required to identify predictors that determine the effect among patients.</p>
<p>The mechanisms for the blood-pressure lowering effect of exercise are complex and not fully understood. HR recovery after an exhaustive exercise test has showed to be mediated by vagal reactivation following the termination of the sympathetically activated state of exercise.<sup><xref ref-type="bibr" rid="bibr27-1741826711400512">27</xref></sup> The observation in our study of reduced HR after exercise is in accordance with other studies<sup><xref ref-type="bibr" rid="bibr5-1741826711400512">5</xref></sup> suggesting an increased vagal tone<sup><xref ref-type="bibr" rid="bibr28-1741826711400512">28</xref></sup> and reduced sympathetic drive.<sup><xref ref-type="bibr" rid="bibr28-1741826711400512">28</xref></sup> HR at rest and HR recovery after exercise testing has also been found to be prognostic markers for CVD and mortality.<sup><xref ref-type="bibr" rid="bibr29-1741826711400512">29</xref></sup> Peak heart rate was reduced in the AIT group after the intervention period was analysed on treatment. This has also been shown in other studies,<sup><xref ref-type="bibr" rid="bibr30-1741826711400512">30</xref></sup> and might be explained by the same mechanisms as described.</p>
<p>In this small study, changes were highly significant in the AIT group only. The effectiveness of AIT as a tool to lower blood pressure is also consistent with both the reduction in peripheral resistance and in-night ABP in the AIT group. Most of earlier studies have not demonstrated a reduction of in-night ABP.<sup><xref ref-type="bibr" rid="bibr31-1741826711400512">31</xref></sup></p>
</sec>
<sec id="sec18-1741826711400512"><title>Echocardiographic findings</title>
<p>AIT improved both the systolic and diastolic function significantly. The changes in tissue Doppler measurements are highly significant, while only borderline in the MIT group. The positive effect of high-intensity exercise on myocardial function in other CVD has been well documented in previous studies,<sup><xref ref-type="bibr" rid="bibr10-1741826711400512">10</xref>,<xref ref-type="bibr" rid="bibr32-1741826711400512">32</xref>,<xref ref-type="bibr" rid="bibr33-1741826711400512">33</xref></sup> but this is, to our knowledge, the first time it has been studied in a hypertensive population. Our study demonstrated an increase in stroke volume, end diastolic volume, and ejection fraction in the AIT group. Although, the AIT group showed a reduction in afterload evidenced by the reduced systolic ABP, they also increased S′, which is a relatively early event in systole and correlates to contractility and is fairly load-independent.<sup><xref ref-type="bibr" rid="bibr34-1741826711400512">34</xref></sup> This might imply that there is a myocardial effect per se, not only an effect of afterload. The direct myocardial effect of training is also implied by the increased EDV in the AIT group.</p>
<p>Diastolic dysfunction is a common finding in hypertension, but our population was within the normal range when indexed for age.<sup><xref ref-type="bibr" rid="bibr35-1741826711400512">35</xref></sup> Previous studies have shown that exercise capacity is closely linked to diastolic function.<sup><xref ref-type="bibr" rid="bibr36-1741826711400512">36</xref></sup> E′ has been shown to be a useful, relatively load independent measure of the left ventricular relaxation rate.<sup><xref ref-type="bibr" rid="bibr34-1741826711400512">34</xref></sup> In our study only the AIT group increased E′. This is in accordance with other exercise studies.<sup><xref ref-type="bibr" rid="bibr33-1741826711400512">33</xref></sup> Increased relaxation rate is also consistent with the decrease in the isovolumic relaxation rate in the AIT group.</p>
</sec>
<sec id="sec19-1741826711400512"><title>VO<sub>2max</sub>, endothelial function, and cardiovascular risk</title>
<p>Vigorous intensity exercise has been shown to increase aerobic fitness more effectively than moderate intensity exercise,<sup><xref ref-type="bibr" rid="bibr9-1741826711400512">9</xref>,<xref ref-type="bibr" rid="bibr12-1741826711400512">12</xref></sup> also when energy expenditure of exercise is held constant. We observed that the AIT group improved their fitness more than the other groups. Aerobic fitness is an independent risk factor in itself, in healthy subjects as well as in patients with hypertension.<sup><xref ref-type="bibr" rid="bibr2-1741826711400512">2</xref>,<xref ref-type="bibr" rid="bibr3-1741826711400512">3</xref></sup> Kokkinos et al. showed that an increase of 1 metabolic equivalent decreased the risk of all-cause mortality by 13% in a hypertensive population.<sup><xref ref-type="bibr" rid="bibr2-1741826711400512">2</xref></sup></p>
<p>The beneficial effect of exercise on endothelial function, including hypertensive patients<sup><xref ref-type="bibr" rid="bibr37-1741826711400512">37</xref></sup> has been described earlier, but in this study, it improved in the AIT group only. One of the main stimuli to the endothelium to increase the bioavailability of nitric oxide is shear stress, and one might speculate if the relatively larger shear stress provided by the high-intensity exercise compared to the moderate intensity training further enhances the endothelial function. Endothelial dysfunction plays a crucial role in the regulation of vasomotor tone and the development of atherosclerosis, and is found to be a strong predictor of CV risk in healthy subjects as well as in hypertensive patients.<sup><xref ref-type="bibr" rid="bibr38-1741826711400512">38</xref></sup></p>
</sec>
<sec id="sec20-1741826711400512"><title>Quality of life</title>
<p>Both training modalities improved the QoL regarding physical health and this is in accordance with other studies.<sup><xref ref-type="bibr" rid="bibr39-1741826711400512">39</xref></sup> The explanation may be of increased aerobic capacity. Interestingly the AIT group also had an improvement in social function. These findings need further investigation, but may be related to general larger improvements in cardiovascular function and the increased aerobic capacity.</p>
</sec>
<sec id="sec21-1741826711400512"><title>Limitations and strengths</title>
<p>The study is relatively small and comes only from an intervention of 12 weeks in a dedicated single centre. This is mainly a study of the physiological effects of training in hypertension. The effect of AIT as treatment, is dependent on factors such as how applicable the training regimen is in a multi-centre setting, the number of patients it is possible to recruit, compliance, and the adherence to training as permanent lifestyle after the first intervention. In this study we did not measure physical activity outside the study, and we did not make any dietary registrations. The training regimes differed not only in intensity, but also by interval versus continuous training, although not in the amount of training, being isocaloric. One person in the moderate intensity group sustained a myocardial infarction when he was home. The numbers of patients in this study are too small to estimate the issue of safety.</p>
<p>The strengths of the study is the strict training programme which is easy to monitor, allowing the study of the physiological effects of the training interventions, and the measurement of progression according to any improvement in aerobic capacity.</p>
</sec>
</sec>
<sec id="sec22-1741826711400512" sec-type="conclusions"><title>Conclusion</title>
<p>In this study high-intensity endurance training at &gt;90% of HR<sub>max</sub> in the form of 3-weekly bouts of interval training for 12 weeks reduced systolic and diastolic ambulatory blood pressure by 12.0 mmHg and 8.0 mmHg, whilst moderate continuous training reduced the systolic and diastolic ambulatory blood pressure by 4.5 and 3.5 mmHg. This study indicates that high-intensity aerobic interval training is more effective to improve aerobic capacity, HR recovery, and cardiac and endothelial function compared to training at continuous moderate intensity.</p>
</sec>
</body>
<back>
<sec id="sec23-1741826711400512"><title>Funding</title>
<p>This work was supported by EXTRA funds from the Norwegian Foundation for Health and Rehabilitation and The Norwegian Heart and Lung Patient Organisation (grant number 2005/2/0218). The funding organizations had no involvement with the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.</p>
</sec>
<sec id="sec24-1741826711400512"><title>Conflicts of interest</title>
<p>None declared.</p>
</sec>
<sec id="sec25-1741826711400512"><title>Clinical trial number</title>
<p>NCT00218972</p>
</sec>
<ref-list>
<title>References</title>
<ref id="bibr1-1741826711400512"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kearney</surname><given-names>PM</given-names></name><name><surname>Whelton</surname><given-names>M</given-names></name><name><surname>Reynolds</surname><given-names>K</given-names></name><name><surname>Muntner</surname><given-names>P</given-names></name><name><surname>Whelton</surname><given-names>PK</given-names></name><name><surname>He</surname><given-names>J</given-names></name></person-group>. <article-title>Global burden of hypertension: analysis of worldwide data</article-title>. <source>Lancet</source> <year>2005</year>; <volume>365</volume>(<issue>9455</issue>): <fpage>217</fpage>–<lpage>223</lpage>.</citation></ref>
<ref id="bibr2-1741826711400512"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kokkinos</surname><given-names>P</given-names></name><name><surname>Manolis</surname><given-names>A</given-names></name><name><surname>Pittaras</surname><given-names>A</given-names></name><name><surname>Doumas</surname><given-names>M</given-names></name><name><surname>Giannelou</surname><given-names>A</given-names></name><name><surname>Panagiotakos</surname><given-names>DB</given-names></name><etal/></person-group>. <article-title>Exercise capacity and mortality in hypertensive men with and without additional risk factors</article-title>. <source>Hypertension</source> <year>2009</year>; <volume>53</volume>(<issue>3</issue>): <fpage>494</fpage>–<lpage>499</lpage>.</citation></ref>
<ref id="bibr3-1741826711400512"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Myers</surname><given-names>J</given-names></name><name><surname>Prakash</surname><given-names>M</given-names></name><name><surname>Froelicher</surname><given-names>V</given-names></name><name><surname>Do</surname><given-names>D</given-names></name><name><surname>Partington</surname><given-names>S</given-names></name><name><surname>Atwood</surname><given-names>E</given-names></name></person-group>. <article-title>Exercise capacity and mortality among men referred for exercise testing</article-title>. <source>N Eng J Med</source> <year>2002</year>; <volume>346</volume>(<issue>11</issue>): <fpage>793</fpage>–<lpage>801</lpage>.</citation></ref>
<ref id="bibr4-1741826711400512"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Boman</surname><given-names>K</given-names></name><name><surname>Gerdts</surname><given-names>E</given-names></name><name><surname>Wachtell</surname><given-names>K</given-names></name><name><surname>Dahlof</surname><given-names>B</given-names></name><name><surname>Nieminen</surname><given-names>MS</given-names></name><name><surname>Olofsson</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Exercise and cardiovascular outcomes in hypertensive patients in relation to structure and function of left ventricular hypertrophy: the LIFE study</article-title>. <source>Eur J Cardiovasc Prev Rehabil</source> <year>2009</year>; <volume>16</volume>(<issue>2</issue>): <fpage>242</fpage>–<lpage>248</lpage>.</citation></ref>
<ref id="bibr5-1741826711400512"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cornelissen</surname><given-names>VA</given-names></name><name><surname>Fagard</surname><given-names>RH</given-names></name></person-group>. <article-title>Effects of endurance training on blood pressure, blood pressure-regulating mechanisms, and cardiovascular risk factors</article-title>. <source>Hypertension</source> <year>2005</year>; <volume>46</volume>(<issue>4</issue>): <fpage>667</fpage>–<lpage>675</lpage>.</citation></ref>
<ref id="bibr6-1741826711400512"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pescatello</surname><given-names>LS</given-names></name><name><surname>Franklin</surname><given-names>BA</given-names></name><name><surname>Fagard</surname><given-names>R</given-names></name><name><surname>Farquhar</surname><given-names>WB</given-names></name><name><surname>Kelley</surname><given-names>GA</given-names></name><name><surname>Ray</surname><given-names>CA</given-names></name></person-group>. <article-title>American College of Sports Medicine position stand. Exercise and hypertension</article-title>. <source>Med Sci Sports Exerc</source> <year>2004</year>; <volume>36</volume>(<issue>3</issue>): <fpage>533</fpage>–<lpage>553</lpage>.</citation></ref>
<ref id="bibr7-1741826711400512"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Graham</surname><given-names>I</given-names></name><name><surname>Atar</surname><given-names>D</given-names></name><name><surname>Borch-Johnsen</surname><given-names>K</given-names></name><name><surname>Boysen</surname><given-names>G</given-names></name><name><surname>Burell</surname><given-names>G</given-names></name><name><surname>Cifkova</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts)</article-title>. <source>Eur J Cardiovasc Prev Rehabil</source> <year>2007</year>; <volume>14 Suppl 2</volume>: <fpage>S1</fpage>–<lpage>S113</lpage>.</citation></ref>
<ref id="bibr8-1741826711400512"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kokkinos</surname><given-names>PF</given-names></name><name><surname>Giannelou</surname><given-names>A</given-names></name><name><surname>Manolis</surname><given-names>A</given-names></name><name><surname>Pittaras</surname><given-names>A</given-names></name></person-group>. <article-title>Physical activity in the prevention and management of high blood pressure</article-title>. <source>Hellenic J Cardiol</source> <year>2009</year>; <volume>50</volume>(<issue>1</issue>): <fpage>52</fpage>–<lpage>59</lpage>.</citation></ref>
<ref id="bibr9-1741826711400512"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Swain</surname><given-names>DP</given-names></name><name><surname>Franklin</surname><given-names>BA</given-names></name></person-group>. <article-title>Comparison of cardioprotective benefits of vigorous versus moderate intensity aerobic exercise</article-title>. <source>Am J Cardiol</source> <year>2006</year>; <volume>97</volume>(<issue>1</issue>): <fpage>141</fpage>–<lpage>147</lpage>.</citation></ref>
<ref id="bibr10-1741826711400512"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wisloff</surname><given-names>U</given-names></name><name><surname>Stoylen</surname><given-names>A</given-names></name><name><surname>Loennechen</surname><given-names>JP</given-names></name><name><surname>Bruvold</surname><given-names>M</given-names></name><name><surname>Rognmo</surname><given-names>O</given-names></name><name><surname>Haram</surname><given-names>PM</given-names></name><etal/></person-group>. <article-title>Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study</article-title>. <source>Circulation</source> <year>2007</year>; <volume>115</volume>(<issue>24</issue>): <fpage>3086</fpage>–<lpage>3094</lpage>.</citation></ref>
<ref id="bibr11-1741826711400512"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rognmo</surname><given-names>O</given-names></name><name><surname>Hetland</surname><given-names>E</given-names></name><name><surname>Helgerud</surname><given-names>J</given-names></name><name><surname>Hoff</surname><given-names>J</given-names></name><name><surname>Slordahl</surname><given-names>SA</given-names></name></person-group>. <article-title>High intensity aerobic interval exercise is superior to moderate intensity exercise for increasing aerobic capacity in patients with coronary artery disease</article-title>. <source>Eur J Cardiovasc Prev Rehabil</source> <year>2004</year>; <volume>11</volume>(<issue>3</issue>): <fpage>216</fpage>–<lpage>222</lpage>.</citation></ref>
<ref id="bibr12-1741826711400512"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wenger</surname><given-names>HA</given-names></name><name><surname>Bell</surname><given-names>GJ</given-names></name></person-group>. <article-title>The interactions of intensity, frequency and duration of exercise training in altering cardiorespiratory fitness</article-title>. <source>Sports Med</source> <year>1986</year>; <volume>3</volume>(<issue>5</issue>): <fpage>346</fpage>–<lpage>356</lpage>.</citation></ref>
<ref id="bibr13-1741826711400512"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tjonna</surname><given-names>AE</given-names></name><name><surname>Lee</surname><given-names>SJ</given-names></name><name><surname>Rognmo</surname><given-names>O</given-names></name><name><surname>Stolen</surname><given-names>TO</given-names></name><name><surname>Bye</surname><given-names>A</given-names></name><name><surname>Haram</surname><given-names>PM</given-names></name><etal/></person-group>. <article-title>Aerobic interval training versus continuous moderate exercise as a treatment for the metabolic syndrome: a pilot study</article-title>. <source>Circulation</source> <year>2008</year>; <volume>118</volume>(<issue>4</issue>): <fpage>346</fpage>–<lpage>354</lpage>.</citation></ref>
<ref id="bibr14-1741826711400512"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cornelissen</surname><given-names>VA</given-names></name><name><surname>Verheyden</surname><given-names>B</given-names></name><name><surname>Aubert</surname><given-names>AE</given-names></name><name><surname>Fagard</surname><given-names>RH</given-names></name></person-group>. <article-title>Effects of aerobic training intensity on resting, exercise and post-exercise blood pressure, heart rate and heart-rate variability</article-title>. <source>J Hum Hypertens</source> <year>2010</year>; <volume>24</volume>(<issue>3</issue>): <fpage>175</fpage>–<lpage>182</lpage>.</citation></ref>
<ref id="bibr15-1741826711400512"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haskell</surname><given-names>WL</given-names></name><name><surname>Lee</surname><given-names>IM</given-names></name><name><surname>Pate</surname><given-names>RR</given-names></name><name><surname>Powell</surname><given-names>KE</given-names></name><name><surname>Blair</surname><given-names>SN</given-names></name><name><surname>Franklin</surname><given-names>BA</given-names></name><etal/></person-group>. <article-title>Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association</article-title>. <source>Circulation</source> <year>2007</year>; <volume>116</volume>(<issue>9</issue>): <fpage>1081</fpage>–<lpage>1093</lpage>.</citation></ref>
<ref id="bibr16-1741826711400512"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Corneliessen</surname><given-names>VA</given-names></name><name><surname>Arnout</surname><given-names>J</given-names></name><name><surname>Holvoet</surname><given-names>P</given-names></name><name><surname>Fagard</surname><given-names>RH</given-names></name></person-group>. <article-title>Influence of exercise at lower and higher intensity on blood pressure and cardiovascular risk factors at older age</article-title>. <source>J Hypertens</source> <year>2009</year>; <volume>27</volume>: <fpage>753</fpage>–<lpage>762</lpage>.</citation></ref>
<ref id="bibr17-1741826711400512"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Palatini</surname><given-names>P</given-names></name><name><surname>Frigo</surname><given-names>G</given-names></name><name><surname>Bertolo</surname><given-names>O</given-names></name><name><surname>Roman</surname><given-names>E</given-names></name><name><surname>Da Corta</surname><given-names>R</given-names></name><name><surname>Winnicki</surname><given-names>M</given-names></name></person-group>. <article-title>Validation of the A&amp;D TM-2430 device for ambulatory blood pressure monitoring and evaluation of performance according to subjects' characteristics</article-title>. <source>Blood Press Monit</source> <year>1998</year>; <volume>3</volume>(<issue>4</issue>): <fpage>255</fpage>–<lpage>260</lpage>.</citation></ref>
<ref id="bibr18-1741826711400512"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wolthuis</surname><given-names>RA</given-names></name><name><surname>Froelicher</surname><given-names>VF</given-names><suffix>Jr</suffix></name><name><surname>Fischer</surname><given-names>J</given-names></name><name><surname>Triebwasser</surname><given-names>JH</given-names></name></person-group>. <article-title>The response of healthy men to treadmill exercise</article-title>. <source>Circulation</source> <year>1977</year>; <volume>55</volume>(<issue>1</issue>): <fpage>153</fpage>–<lpage>157</lpage>.</citation></ref>
<ref id="bibr19-1741826711400512"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Corretti</surname><given-names>MC</given-names></name><name><surname>Anderson</surname><given-names>TJ</given-names></name><name><surname>Benjamin</surname><given-names>EJ</given-names></name><name><surname>Celermajer</surname><given-names>D</given-names></name><name><surname>Charbonneau</surname><given-names>F</given-names></name><name><surname>Creager</surname><given-names>MA</given-names></name><etal/></person-group>. <article-title>Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force</article-title>. <source>J Am Coll Cardiol</source> <year>2002</year>; <volume>39</volume>(<issue>2</issue>): <fpage>257</fpage>–<lpage>265</lpage>.</citation></ref>
<ref id="bibr20-1741826711400512"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vickers</surname><given-names>AJ</given-names></name><name><surname>Altman</surname><given-names>DG</given-names></name></person-group>. <article-title>Statistics notes: Analysing controlled trials with baseline and follow up measurements</article-title>. <source>BMJ</source> <year>2001</year>; <volume>323</volume>(<issue>7321</issue>): <fpage>1123</fpage>–<lpage>1124</lpage>.</citation></ref>
<ref id="bibr21-1741826711400512"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Whelton</surname><given-names>SP</given-names></name><name><surname>Chin</surname><given-names>A</given-names></name><name><surname>Xin</surname><given-names>X</given-names></name><name><surname>He</surname><given-names>J</given-names></name></person-group>. <article-title>Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials</article-title>. <source>Ann Intern Med</source> <year>2002</year>; <volume>136</volume>(<issue>7</issue>): <fpage>493</fpage>–<lpage>503</lpage>.</citation></ref>
<ref id="bibr22-1741826711400512"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nemoto</surname><given-names>K</given-names></name><name><surname>Gen-no</surname><given-names>H</given-names></name><name><surname>Masuki</surname><given-names>S</given-names></name><name><surname>Okazaki</surname><given-names>K</given-names></name><name><surname>Nose</surname><given-names>H</given-names></name></person-group>. <article-title>Effects of high-intensity interval walking training on physical fitness and blood pressure in middle-aged and older people</article-title>. <source>Mayo Clin Proc</source> <year>2007</year>; <volume>82</volume>(<issue>7</issue>): <fpage>803</fpage>–<lpage>811</lpage>.</citation></ref>
<ref id="bibr23-1741826711400512"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marceau</surname><given-names>M</given-names></name><name><surname>Kouame</surname><given-names>N</given-names></name><name><surname>Lacourciere</surname><given-names>Y</given-names></name><name><surname>Cleroux</surname><given-names>J</given-names></name></person-group>. <article-title>Effects of different training intensities on 24-hour blood pressure in hypertensive subjects</article-title>. <source>Circulation</source> <year>1993</year>; <volume>88</volume>(<issue>6</issue>): <fpage>2803</fpage>–<lpage>2811</lpage>.</citation></ref>
<ref id="bibr24-1741826711400512"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>PD</given-names></name><name><surname>Crouse</surname><given-names>SF</given-names></name><name><surname>Goodpaster</surname><given-names>B</given-names></name><name><surname>Kelley</surname><given-names>D</given-names></name><name><surname>Moyna</surname><given-names>N</given-names></name><name><surname>Pescatello</surname><given-names>L</given-names></name></person-group>. <article-title>The acute versus the chronic response to exercise</article-title>. <source>Med Sci Sports Exerc</source> <year>2001</year>; <volume>33</volume>(<issue>6 Suppl</issue>): <fpage>S438</fpage>–<lpage>45</lpage>. <comment>discussion S452–S453</comment>.</citation></ref>
<ref id="bibr25-1741826711400512"><label>25</label><citation citation-type="journal"><name><surname>Eicher</surname><given-names>JD</given-names></name><name><surname>Maresh</surname><given-names>CM</given-names></name><name><surname>Tsongalis</surname><given-names>GJ</given-names></name><name><surname>Thompson</surname><given-names>PD</given-names></name><name><surname>Pescatello</surname><given-names>LS</given-names></name>. <article-title>The additive blood pressure lowering effects of exercise intensity on post-exercise hypotension</article-title>. <source>Am heart J</source> <year>2010</year>; <volume>160</volume>(<issue>3</issue>): <fpage>513</fpage>–<lpage>520</lpage>.</citation></ref>
<ref id="bibr26-1741826711400512"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wald</surname><given-names>DS</given-names></name><name><surname>Law</surname><given-names>M</given-names></name><name><surname>Morris</surname><given-names>JK</given-names></name><name><surname>Bestwick</surname><given-names>JP</given-names></name><name><surname>Wald</surname><given-names>NJ</given-names></name></person-group>. <article-title>Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials</article-title>. <source>Am J Med</source> <year>2009</year>; <volume>122</volume>(<issue>3</issue>): <fpage>290</fpage>–<lpage>300</lpage>.</citation></ref>
<ref id="bibr27-1741826711400512"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shetler</surname><given-names>K</given-names></name><name><surname>Marcus</surname><given-names>R</given-names></name><name><surname>Froelicher</surname><given-names>VF</given-names></name><name><surname>Vora</surname><given-names>S</given-names></name><name><surname>Kalisetti</surname><given-names>D</given-names></name><name><surname>Prakash</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Heart rate recovery: validation and methodologic issues</article-title>. <source>J Am Coll Cardiol</source> <year>2001</year>; <volume>38</volume>(<issue>7</issue>): <fpage>1980</fpage>–<lpage>1987</lpage>.</citation></ref>
<ref id="bibr28-1741826711400512"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Collier</surname><given-names>SR</given-names></name><name><surname>Kanaley</surname><given-names>JA</given-names></name><name><surname>Carhart</surname><given-names>R</given-names><suffix>Jr</suffix></name><name><surname>Frechette</surname><given-names>V</given-names></name><name><surname>Tobin</surname><given-names>MM</given-names></name><name><surname>Bennett</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>Cardiac autonomic function and baroreflex changes following 4 weeks of resistance versus aerobic training in individuals with pre-hypertension</article-title>. <source>Acta Physiol (Oxf)</source> <year>2009</year>; <volume>195</volume>(<issue>3</issue>): <fpage>339</fpage>–<lpage>348</lpage>.</citation></ref>
<ref id="bibr29-1741826711400512"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thayer</surname><given-names>JF</given-names></name><name><surname>Lane</surname><given-names>RD</given-names></name></person-group>. <article-title>The role of vagal function in the risk for cardiovascular disease and mortality</article-title>. <source>Biol Psychol</source> <year>2007</year>; <volume>74</volume>(<issue>2</issue>): <fpage>224</fpage>–<lpage>242</lpage>.</citation></ref>
<ref id="bibr30-1741826711400512"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zavorsky</surname><given-names>GS</given-names></name></person-group>. <article-title>Evidence and possible mechanisms of altered maximum heart rate with endurance training and tapering</article-title>. <source>Sports Med</source> <year>2000</year>; <volume>29</volume>(<issue>1</issue>): <fpage>13</fpage>–<lpage>26</lpage>.</citation></ref>
<ref id="bibr31-1741826711400512"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fagard</surname><given-names>RH</given-names></name><name><surname>Cornelissen</surname><given-names>VA</given-names></name></person-group>. <article-title>Effect of exercise on blood pressure control in hypertensive patients</article-title>. <source>Eur J Cardiovasc Prev Rehabil</source> <year>2007</year>; <volume>14</volume>(<issue>1</issue>): <fpage>12</fpage>–<lpage>17</lpage>.</citation></ref>
<ref id="bibr32-1741826711400512"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Slordahl</surname><given-names>SA</given-names></name><name><surname>Wang</surname><given-names>E</given-names></name><name><surname>Hoff</surname><given-names>J</given-names></name><name><surname>Kemi</surname><given-names>OJ</given-names></name><name><surname>Amundsen</surname><given-names>BH</given-names></name><name><surname>Helgerud</surname><given-names>J</given-names></name></person-group>. <article-title>Effective training for patients with intermittent claudication</article-title>. <source>Scand Cardiovasc J</source> <year>2005</year>; <volume>39</volume>(<issue>4</issue>): <fpage>244</fpage>–<lpage>249</lpage>.</citation></ref>
<ref id="bibr33-1741826711400512"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Amundsen</surname><given-names>BH</given-names></name><name><surname>Rognmo</surname><given-names>O</given-names></name><name><surname>Hatlen-Rebhan</surname><given-names>G</given-names></name><name><surname>Slordahl</surname><given-names>SA</given-names></name></person-group>. <article-title>High-intensity aerobic exercise improves diastolic function in coronary artery disease</article-title>. <source>Scand Cardiovasc J</source> <year>2008</year>; <volume>42</volume>(<issue>2</issue>): <fpage>110</fpage>–<lpage>117</lpage>.</citation></ref>
<ref id="bibr34-1741826711400512"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gulati</surname><given-names>VK</given-names></name><name><surname>Katz</surname><given-names>WE</given-names></name><name><surname>Follansbee</surname><given-names>WP</given-names></name><name><surname>Gorcsan</surname><given-names>J</given-names><suffix>3rd</suffix></name></person-group>. <article-title>Mitral annular descent velocity by tissue Doppler echocardiography as an index of global left ventricular function</article-title>. <source>Am J Cardiol</source> <year>1996</year>; <volume>77</volume>(<issue>11</issue>): <fpage>979</fpage>–<lpage>984</lpage>.</citation></ref>
<ref id="bibr35-1741826711400512"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mottram</surname><given-names>PM</given-names></name><name><surname>Marwick</surname><given-names>TH</given-names></name></person-group>. <article-title>Assessment of diastolic function: what the general cardiologist needs to know</article-title>. <source>Heart</source> <year>2005</year>; <volume>91</volume>: <fpage>681</fpage>–<lpage>695</lpage>.</citation></ref>
<ref id="bibr36-1741826711400512"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gledhill</surname><given-names>N</given-names></name><name><surname>Cox</surname><given-names>D</given-names></name><name><surname>Jamnik</surname><given-names>R</given-names></name></person-group>. <article-title>Endurance athletes' stroke volume does not plateau: major advantage is diastolic function</article-title>. <source>Med Sci Sports Exerc</source> <year>1994</year>; <volume>26</volume>(<issue>9</issue>): <fpage>1116</fpage>–<lpage>1121</lpage>.</citation></ref>
<ref id="bibr37-1741826711400512"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Higashi</surname><given-names>Y</given-names></name><name><surname>Sasaki</surname><given-names>S</given-names></name><name><surname>Kurisu</surname><given-names>S</given-names></name><name><surname>Yoshimizu</surname><given-names>A</given-names></name><name><surname>Sasaki</surname><given-names>N</given-names></name><name><surname>Matsuura</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Regular aerobic exercise augments endothelium-dependent vascular relaxation in normotensive as well as hypertensive subjects: role of endothelium-derived nitric oxide</article-title>. <source>Circulation</source> <year>1999</year>; <volume>100</volume>(<issue>11</issue>): <fpage>1194</fpage>–<lpage>1202</lpage>.</citation></ref>
<ref id="bibr38-1741826711400512"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Muiesan</surname><given-names>ML</given-names></name><name><surname>Salvetti</surname><given-names>M</given-names></name><name><surname>Paini</surname><given-names>A</given-names></name><name><surname>Monteduro</surname><given-names>C</given-names></name><name><surname>Galbassini</surname><given-names>G</given-names></name><name><surname>Poisa</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Prognostic role of flow-mediated dilatation of the brachial artery in hypertensive patients</article-title>. <source>J Hypertens</source> <year>2008</year>; <volume>26</volume>(<issue>8</issue>): <fpage>1612</fpage>–<lpage>1618</lpage>.</citation></ref>
<ref id="bibr39-1741826711400512"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>JC</given-names></name><name><surname>Yang</surname><given-names>HY</given-names></name><name><surname>Wang</surname><given-names>WH</given-names></name><name><surname>Hsieh</surname><given-names>MH</given-names></name><name><surname>Chen</surname><given-names>PT</given-names></name><name><surname>Kao</surname><given-names>CC</given-names></name><etal/></person-group>. <article-title>The beneficial effect of regular endurance exercise training on blood pressure and quality of life in patients with hypertension</article-title>. <source>Clin Exp Hypertens</source> <year>2004</year>; <volume>26</volume>(<issue>3</issue>): <fpage>255</fpage>–<lpage>265</lpage>.</citation></ref>
</ref-list>
</back>
</article>